Glucose Health, Inc. (GLUC) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US3798941080
Glucose Health, Inc. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 384,078.00 USD | 340,659.00 USD |
| Gross profit | 75,542.00 USD | 119,220.00 USD |
| Operating income | -306,555.00 USD | -199,804.00 USD |
| Net income | -315,930.00 USD | -230,702.00 USD |
Full history since 2007, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Glucose Health, Inc.
Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas.
More stocks
- YUNHONG GREEN CTI LTD. (YHGJ)
- MDB Capital Holdings, LLC (MDBH)
- NON INVASIVE MONITORING SYSTEMS INC /FL/ (NIMU)
- EQUATOR Beverage Co (MOJO)
- TerraVolt Holdings, Inc. (GEDC)
- AETHLON MEDICAL INC (AEMD)
- CISO Global, Inc. (CISO)
- AETERNUM HEALTH, INC. (AETN)
- ACCURAY INC (ARAY)
- INNOVATIVE DESIGNS INC (IVDN)
- GREENLITE VENTURES INC (GRNL)
- Moleculin Biotech, Inc. (MBRX)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.